BMJ 1995;311:573 (26 August)
Letters
Cost effective strategies for reducing coronary risk in primary care
EDITOR,--The implication of K Field and colleagues' paper seems to be that the cost of screening in cardiovascular prevention is high in primary care, particularly when the screening is not targeted at high risk patients.1 I agree with this but disagree with the model used in the paper to assess the cost effectiveness of reducing coronary risk. I think that the message to purchasers that we should use lipid lowering treatment only in patients with cholesterol concentrations above 9.5 mmol/l is dangerous. This is reminiscent of the nonsensical recommendation made by the Scottish Home and Health Department some years ago for a cut off of 10 mmol/l.
It is naive to estimate benefits simply on the basis of total cholesterol concentration, particularly when examining a population of women. Up to a quarter of women aged 35 or more have a high high density lipoprotein cholesterol concentration, but many of these . . . [Full text of this article]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Relevant Article
-
Strategies for reducing coronary risk factors in primary care: which is most cost effective?
- K Field, M Thorogood, C Silagy, C Normand, C O'Neill, and J Muir
BMJ 1995 310: 1109-1112.
[Abstract]
[Full Text]
This article has been cited by other articles:
-
l'Hoir, M P, Engelberts, A C, van Well, G T. J, Westers, P, Mellenbergh, G J, Wolters, W H G, Huber, J
(1998). Case-control study of current validity of previously described risk factors for SIDS in the Netherlands. Arch. Dis. Child.
79: 386-393
[Abstract]
[Full text]